Skip to main content

TB406

WHO Product ID
TB406
Status
Prequalified
INN, dosage form and strength
Ethambutol hydrochloride Tablet, Dispersible 100mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
Tuberculosis
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Dispersible
Applicant organization
Cadila Pharmaceuticals Ltd
1389 Trasad Road, Dholka
Ahmedabad,
Gujarat
382 225
India
Packaging details and storage conditions
Packaging Type
Blister, Alu/Alu
Configuration
10x10
Shelf life (months)
24
Storage conditions
Do not store above 30°C, avoid excursions above 30°C
Packaging Type
Strips, Alu/Alu
Configuration
10x10
Shelf life (months)
24
Storage conditions
Do not store above 30°C, avoid excursions above 30°C
API Manufacturing Site(s)
By Organization
By Active Ingredient
Lupin Ltd
Plot No. 09, 123, 123/1, 124 & 125 -Ethambutol (ETB) Plant, GIDC Estate
Ankleshwar,
Gujarat
393 002
India
Ethambutol hydrochloride
FPP Manufacturing Site(s)
Cadila Pharmaceuticals Ltd
1389 Trasad Road, Dholka
Ahmedabad,
Gujarat
382 225
India
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorized for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , Part 4 , Part 5 , Part 6 , Part 7 , Part 8

.